Cargando…

Cartilage destruction by matrix degradation products

The progressive destruction of articular cartilage is one of the hallmarks of osteoarthritis and rheumatoid arthritis. Cartilage degradation is attributed to different classes of catabolic factors, including proinflammatory cytokines, aggrecanases, matrix metalloproteinases, and nitric oxide. Recent...

Descripción completa

Detalles Bibliográficos
Autor principal: Yasuda, Tadashi
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780665/
https://www.ncbi.nlm.nih.gov/pubmed/16906368
http://dx.doi.org/10.1007/s10165-006-0490-6
_version_ 1782174514514231296
author Yasuda, Tadashi
author_facet Yasuda, Tadashi
author_sort Yasuda, Tadashi
collection PubMed
description The progressive destruction of articular cartilage is one of the hallmarks of osteoarthritis and rheumatoid arthritis. Cartilage degradation is attributed to different classes of catabolic factors, including proinflammatory cytokines, aggrecanases, matrix metalloproteinases, and nitric oxide. Recently, matrix degradation products generated by excessive proteolysis in arthritis have been found to mediate cartilage destruction. These proteolytic fragments activate chondrocytes and synovial fibroblasts via specific cell surface receptors that can stimulate catabolic intracellular signaling pathways, leading to the induction of such catalysts. This review describes the catabolic activities of matrix degradation products, especially fibronectin fragments, and discusses the pathologic implication in cartilage destruction in osteoarthritis and rheumatoid arthritis. Increased levels of these degradation products, found in diseased joints, may stimulate cartilage breakdown by mechanisms of the kind demonstrated in the review.
format Text
id pubmed-2780665
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-27806652009-11-23 Cartilage destruction by matrix degradation products Yasuda, Tadashi Mod Rheumatol Review Article The progressive destruction of articular cartilage is one of the hallmarks of osteoarthritis and rheumatoid arthritis. Cartilage degradation is attributed to different classes of catabolic factors, including proinflammatory cytokines, aggrecanases, matrix metalloproteinases, and nitric oxide. Recently, matrix degradation products generated by excessive proteolysis in arthritis have been found to mediate cartilage destruction. These proteolytic fragments activate chondrocytes and synovial fibroblasts via specific cell surface receptors that can stimulate catabolic intracellular signaling pathways, leading to the induction of such catalysts. This review describes the catabolic activities of matrix degradation products, especially fibronectin fragments, and discusses the pathologic implication in cartilage destruction in osteoarthritis and rheumatoid arthritis. Increased levels of these degradation products, found in diseased joints, may stimulate cartilage breakdown by mechanisms of the kind demonstrated in the review. Springer-Verlag 2006-08 /pmc/articles/PMC2780665/ /pubmed/16906368 http://dx.doi.org/10.1007/s10165-006-0490-6 Text en © Japan College of Rheumatology 2006
spellingShingle Review Article
Yasuda, Tadashi
Cartilage destruction by matrix degradation products
title Cartilage destruction by matrix degradation products
title_full Cartilage destruction by matrix degradation products
title_fullStr Cartilage destruction by matrix degradation products
title_full_unstemmed Cartilage destruction by matrix degradation products
title_short Cartilage destruction by matrix degradation products
title_sort cartilage destruction by matrix degradation products
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780665/
https://www.ncbi.nlm.nih.gov/pubmed/16906368
http://dx.doi.org/10.1007/s10165-006-0490-6
work_keys_str_mv AT yasudatadashi cartilagedestructionbymatrixdegradationproducts